233 related articles for article (PubMed ID: 23926332)
1. Mov10 and APOBEC3G localization to processing bodies is not required for virion incorporation and antiviral activity.
Izumi T; Burdick R; Shigemi M; Plisov S; Hu WS; Pathak VK
J Virol; 2013 Oct; 87(20):11047-62. PubMed ID: 23926332
[TBL] [Abstract][Full Text] [Related]
2. P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages.
Burdick R; Smith JL; Chaipan C; Friew Y; Chen J; Venkatachari NJ; Delviks-Frankenberry KA; Hu WS; Pathak VK
J Virol; 2010 Oct; 84(19):10241-53. PubMed ID: 20668078
[TBL] [Abstract][Full Text] [Related]
3. Moloney leukemia virus 10 (MOV10) inhibits the degradation of APOBEC3G through interference with the Vif-mediated ubiquitin-proteasome pathway.
Chen C; Ma X; Hu Q; Li X; Huang F; Zhang J; Pan T; Xia J; Liu C; Zhang H
Retrovirology; 2017 Dec; 14(1):56. PubMed ID: 29258557
[TBL] [Abstract][Full Text] [Related]
4. APOBEC3G inhibits microRNA-mediated repression of translation by interfering with the interaction between Argonaute-2 and MOV10.
Liu C; Zhang X; Huang F; Yang B; Li J; Liu B; Luo H; Zhang P; Zhang H
J Biol Chem; 2012 Aug; 287(35):29373-83. PubMed ID: 22791714
[TBL] [Abstract][Full Text] [Related]
5. 7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G.
Wang T; Tian C; Zhang W; Luo K; Sarkis PT; Yu L; Liu B; Yu Y; Yu XF
J Virol; 2007 Dec; 81(23):13112-24. PubMed ID: 17881443
[TBL] [Abstract][Full Text] [Related]
6. APOBEC3G complexes decrease human immunodeficiency virus type 1 production.
Martin KL; Johnson M; D'Aquila RT
J Virol; 2011 Sep; 85(18):9314-26. PubMed ID: 21752914
[TBL] [Abstract][Full Text] [Related]
7. Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules.
Gallois-Montbrun S; Kramer B; Swanson CM; Byers H; Lynham S; Ward M; Malim MH
J Virol; 2007 Mar; 81(5):2165-78. PubMed ID: 17166910
[TBL] [Abstract][Full Text] [Related]
8. APOBEC3G: an intracellular centurion.
Chiu YL; Greene WC
Philos Trans R Soc Lond B Biol Sci; 2009 Mar; 364(1517):689-703. PubMed ID: 19008196
[TBL] [Abstract][Full Text] [Related]
9. Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA.
Friew YN; Boyko V; Hu WS; Pathak VK
Retrovirology; 2009 Jun; 6():56. PubMed ID: 19497112
[TBL] [Abstract][Full Text] [Related]
10. Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H.
Soros VB; Yonemoto W; Greene WC
PLoS Pathog; 2007 Feb; 3(2):e15. PubMed ID: 17291161
[TBL] [Abstract][Full Text] [Related]
11. The cellular source for APOBEC3G's incorporation into HIV-1.
Ma J; Li X; Xu J; Zhang Q; Liu Z; Jia P; Zhou J; Guo F; You X; Yu L; Zhao L; Jiang J; Cen S
Retrovirology; 2011 Jan; 8():2. PubMed ID: 21211018
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HIV-1 infection and replication by enhancing viral incorporation of innate anti-HIV-1 protein A3G: a non-pathogenic Nef mutant-based anti-HIV strategy.
Green LA; Liu Y; He JJ
J Biol Chem; 2009 May; 284(20):13363-13372. PubMed ID: 19324886
[TBL] [Abstract][Full Text] [Related]
14. Biochemical fractionation and purification of high-molecular-mass APOBEC3G complexes.
Chiu YL
Methods Mol Biol; 2011; 718():185-206. PubMed ID: 21370050
[TBL] [Abstract][Full Text] [Related]
15. Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions.
Xu H; Chertova E; Chen J; Ott DE; Roser JD; Hu WS; Pathak VK
Virology; 2007 Apr; 360(2):247-56. PubMed ID: 17126871
[TBL] [Abstract][Full Text] [Related]
16. Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.
Svarovskaia ES; Xu H; Mbisa JL; Barr R; Gorelick RJ; Ono A; Freed EO; Hu WS; Pathak VK
J Biol Chem; 2004 Aug; 279(34):35822-8. PubMed ID: 15210704
[TBL] [Abstract][Full Text] [Related]
17. Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1.
Apolonia L; Schulz R; Curk T; Rocha P; Swanson CM; Schaller T; Ule J; Malim MH
PLoS Pathog; 2015 Jan; 11(1):e1004609. PubMed ID: 25590131
[TBL] [Abstract][Full Text] [Related]
18. Identification of molecular determinants from Moloney leukemia virus 10 homolog (MOV10) protein for virion packaging and anti-HIV-1 activity.
Abudu A; Wang X; Dang Y; Zhou T; Xiang SH; Zheng YH
J Biol Chem; 2012 Jan; 287(2):1220-8. PubMed ID: 22105071
[TBL] [Abstract][Full Text] [Related]
19. The roles of APOBEC3G complexes in the incorporation of APOBEC3G into HIV-1.
Ma J; Li X; Xu J; Zhang Q; Liu Z; Jia P; Zhou J; Guo F; You X; Yu L; Zhao L; Jiang J; Cen S
PLoS One; 2013; 8(10):e74892. PubMed ID: 24098356
[TBL] [Abstract][Full Text] [Related]
20. GANP interacts with APOBEC3G and facilitates its encapsidation into the virions to reduce HIV-1 infectivity.
Maeda K; Almofty SA; Singh SK; Eid MMA; Shimoda M; Ikeda T; Koito A; Pham P; Goodman MF; Sakaguchi N
J Immunol; 2013 Dec; 191(12):6030-6039. PubMed ID: 24198285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
